Skip to content

The Effect of L-arginine in the treatment of Sickle Cell Anemia

Double Blind Randomized Trial for L-arginine Effectineness study as a coadjuvante therapeutic protocol in the treatment of Sickle Cell Anemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2t56nz
Enrollment
Unknown
Registered
2017-10-24
Start date
2016-03-03
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sickle cell anemia

Interventions

It is a randomized double-blind placebo-controlled clinical study with adult patients of both sexes, with molecular diagnosis of SCA, in continuous use of HU, at doses from 500mg to 2000mg mg / day, i
Other
G07.203.300.456

Sponsors

Universidade Federal do Ceará
Lead Sponsor
Universidade Federal do Ceará
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients volunteers between 18 and 80 years with sickle cell anemia; both genders; in use of hydroxiurea from 500mg per day; baseline

Exclusion criteria

Exclusion criteria: Patients who do not have sickle cell anemia; Patients who refuse to participate in the study not signing the ethic term; those who have had transfusional therapy in the last three months; patients using iron chelator and antioxidant vitamins; patients smokers and drinkers; pregnant or with diabetes mellitus or with some picture of renal or hepatic insufficiency

Design outcomes

Primary

MeasureTime frame
Increased nitrite levels in the 4-month clinical trial using the ELISA kit for the amount of plasma nitrite in the patient's plasma in grams per liter;There was a significant increase analyzed by p value of 0.004 after 4 months treatment There was a significant increase analyzed by the p-value of 0.004 after the 4-month treatment mentioned above The nitrite levels before treatment were 38.27 g per L, standard deviation of 17.27, to 34.45 g per L, standard deviation of 11.25 after four months of treatment The study group obtained nitrite levels before starting treatment of 36.55 g per L, with a standard deviation of 20.23 to 48.64, with a standard deviation of 20.63 after four months of treatment

Secondary

MeasureTime frame
Reduction of pain frequency during treatment, from pain once a day to once a week, analyzed through each patient's questionnaire;The patients in the study group reduced that pain frequency with p of 0.027 after 4 months treatment

Countries

Brazil

Contacts

Public ContactRenata Eleuterio

Universidade Federal do Ceará

renatameleuterio@gmail.com+55-085-33668262

Outcome results

None listed

Source: REBEC (via WHO ICTRP)